UNRESECTABLE MELANOMA
Clinical trials for UNRESECTABLE MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a second drug boost cancer treatment power?
Disease control CompletedThis study tested whether adding the drug bevacizumab to standard immunotherapy (ipilimumab) could help patients with advanced melanoma live longer. It involved 169 adults whose cancer could not be removed by surgery. Participants were randomly assigned to receive either the sing…
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New combo therapy fights back against Tough-to-Treat skin cancer
Disease control CompletedThis study tested a new combination treatment for people with advanced melanoma that had stopped responding to standard immunotherapy. It combined an experimental cancer vaccine (BNT111) with an existing immunotherapy drug (cemiplimab) to see if it could shrink tumors. The trial …
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug duo tested for Tough-to-Treat skin cancer
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of combining two existing cancer drugs, trametinib and ceritinib, in patients with advanced melanoma that could not be surgically removed. It involved 27 patients whose cancer had worsened despite previous standar…
Matched conditions: UNRESECTABLE MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC